200 related articles for article (PubMed ID: 32291398)
21. Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays.
Ilie MI; Lassalle S; Long-Mira E; Bonnetaud C; Bordone O; Lespinet V; Lamy A; Sabourin JC; Haudebourg J; Butori C; Guevara N; Peyrottes I; Sadoul JL; Bozec A; Santini J; Capper D; von Deimling A; Emile JF; Hofman V; Hofman P
Thyroid; 2014 May; 24(5):858-66. PubMed ID: 24417277
[TBL] [Abstract][Full Text] [Related]
22. Papillary thyroid carcinoma with nodular fasciitis-like stroma: A rare variant with distinctive morphology.
Mardi K
Indian J Pathol Microbiol; 2017; 60(3):390-392. PubMed ID: 28937378
[TBL] [Abstract][Full Text] [Related]
23. Stromal modulation and its role in the diagnosis of papillary patterned thyroid lesions.
Daoud SA; Esmail RS; Hareedy AA; Khalil A
Asian Pac J Cancer Prev; 2015; 16(8):3307-12. PubMed ID: 25921136
[TBL] [Abstract][Full Text] [Related]
24. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M
Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206
[TBL] [Abstract][Full Text] [Related]
25. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
Geng Q; Deng H; Fu J; Cui F
Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
[TBL] [Abstract][Full Text] [Related]
26. Scarring in papillary carcinoma of the thyroid: report of two new cases with exuberant nodular fasciitis-like stroma.
Toti P; Tanganelli P; Schürfeld K; Stumpo M; Barbagli L; Vatti R; Luzi P
Histopathology; 1999 Nov; 35(5):418-22. PubMed ID: 10583556
[TBL] [Abstract][Full Text] [Related]
27. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
28. Papillary carcinoma with nodular fasciitis-like stroma--a case report in pregnancy.
Leal II; Carneiro FP; Basílio-de-Oliveira CA; Magalhães AV; Barbosa TW; da Silva FP; de Castro Montenegro FS
Diagn Cytopathol; 2008 Mar; 36(3):139-41. PubMed ID: 18232002
[TBL] [Abstract][Full Text] [Related]
29. Anaplastic spindle cell squamous carcinoma arising from classical papillary thyroid carcinoma with foci of columnar cell component: A case report.
Wang K; Shi N; Yu M; Zhou W; Wang X; Wang C
Tissue Cell; 2021 Dec; 73():101666. PubMed ID: 34678532
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.
Fisher KE; Jani JC; Fisher SB; Foulks C; Hill CE; Weber CJ; Cohen C; Sharma J
J Surg Res; 2013 Nov; 185(1):217-24. PubMed ID: 23746767
[TBL] [Abstract][Full Text] [Related]
31. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.
Zou M; Baitei EY; Alzahrani AS; BinHumaid FS; Alkhafaji D; Al-Rijjal RA; Meyer BF; Shi Y
Thyroid; 2014 Aug; 24(8):1256-66. PubMed ID: 24798740
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Immunohistochemistry and Direct Sequencing Methods for Identification of the BRAF
Kim JK; Seong CY; Bae IE; Yi JW; Yu HW; Kim SJ; Won JK; Chai YJ; Choi JY; Lee KE
Ann Surg Oncol; 2018 Jun; 25(6):1775-1781. PubMed ID: 29611028
[TBL] [Abstract][Full Text] [Related]
33. Papillary thyroid carcinoma with nodular fasciitis-like stroma. Pitfalls in fine-needle aspiration cytology.
Yang YJ; LiVolsi VA; Khurana KK
Arch Pathol Lab Med; 1999 Sep; 123(9):838-41. PubMed ID: 10458836
[TBL] [Abstract][Full Text] [Related]
34. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: case report and literature review.
Oishi N; Kondo T; Nakazawa T; Mochizuki K; Kasai K; Inoue T; Yamamoto T; Watanabe H; Hatsushika K; Masuyama K; Katoh R
Pathol Res Pract; 2014 Dec; 210(12):1142-5. PubMed ID: 24893893
[TBL] [Abstract][Full Text] [Related]
35. Caveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation status.
Paskaš S; Janković J; Marečko I; Išić Denčić T; Tatić S; Cvejić D; Savin S
Otolaryngol Head Neck Surg; 2014 Feb; 150(2):201-9. PubMed ID: 24255086
[TBL] [Abstract][Full Text] [Related]
36. Papillary thyroid cancer stroma - histological and immunohistochemical study.
Radu TG; Ciurea ME; Mogoantă SŞ; Busuioc CJ; Grosu F; Ţenovici M; Petrescu IO; Vladu IM
Rom J Morphol Embryol; 2016; 57(2 Suppl):801-809. PubMed ID: 27833974
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic Properties of the Antisense lncRNA
Esposito R; Esposito D; Pallante P; Fusco A; Ciccodicola A; Costa V
Cancer Res; 2019 May; 79(9):2124-2135. PubMed ID: 30862713
[No Abstract] [Full Text] [Related]
38. Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii.
Tan A; Stewart CJ; Garrett KL; Rye M; Cohen PA
Endocr Pathol; 2015 Dec; 26(4):296-301. PubMed ID: 26362194
[TBL] [Abstract][Full Text] [Related]
39. Papillary carcinoma of the thyroid with exuberant nodular fasciitis-like stroma.
Terayama K; Toda S; Yonemitsu N; Koike N; Sugihara H
Virchows Arch; 1997 Oct; 431(4):291-5. PubMed ID: 9368667
[TBL] [Abstract][Full Text] [Related]
40. Tall Cell Variant of Papillary Thyroid Carcinoma: Impact of Change in WHO Definition and Molecular Analysis.
Wong KS; Higgins SE; Marqusee E; Nehs MA; Angell T; Barletta JA
Endocr Pathol; 2019 Mar; 30(1):43-48. PubMed ID: 30565013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
